Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
12.21
+0.38 (3.21%)
Apr 28, 2025, 4:00 PM EDT - Market closed

Cartesian Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
316461107--
Market Cap Growth
330.61%330.61%---
Enterprise Value
118256123--
Last Close Price
12.2117.9120.68--
PS Ratio
5.4211.844.12--
PB Ratio
-46.50-67.74-0.77--
EV/Sales Ratio
3.026.584.75--
Debt / Equity Ratio
-2.06-2.06-0.080.400.18
Debt / EBITDA Ratio
---2.01-
Asset Turnover
0.110.110.111.26-
Quick Ratio
9.299.291.265.766.38
Current Ratio
9.439.431.335.916.42
Return on Equity (ROE)
---70.21%-
Return on Assets (ROA)
-6.00%-6.00%-19.75%10.35%-
Return on Capital (ROIC)
---3021.69%12.98%-
Return on Capital Employed (ROCE)
---10.30%-
Earnings Yield
-24.48%-16.80%-205.34%--
FCF Yield
-10.36%-7.11%-48.01%--
Buyback Yield / Dilution
-235.72%-235.72%-6.33%-27.59%-
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q